Jane Huang is CMO at BeiGene, Ltd. (BGNE). They have made 53 open-market trades across 2 companies since 2017, most recently 2025-10-04.
CIK 0001683913
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 53 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRLD | SELL | 2023-04-06 | 2023-04-06 | $6.12 | $163K | +7.9% | +5.1% | -23.3% |
| BGNE | SELL | 2021-12-14 | 2021-12-16 | $278.14 | $417K | -0.5% | -8.6% | -30.0% |
| BGNE | SELL | 2021-12-01 | 2021-12-02 | $359.86 | $755K | -20.4% | -22.9% | -38.7% |
| BGNE | SELL | 2021-11-17 | 2021-11-19 | $381.34 | $572K | -5.1% | -24.9% | -43.7% |
| BGNE | SELL | 2021-10-19 | 2021-10-21 | $372.78 | $559K | -4.5% | -5.5% | -36.9% |
| BGNE | SELL | 2021-09-20 | 2021-09-22 | $397.47 | $3.6M | -6.6% | -0.0% | -27.4% |
| BGNE | SELL | 2021-09-13 | 2021-09-15 | $357.91 | $6.7M | -1.2% | -6.1% | -27.1% |
| BGNE | SELL | 2021-09-01 | 2021-09-02 | $318.88 | $693K | +12.4% | +5.9% | +5.4% |
| BGNE | SELL | 2021-07-15 | 2021-07-19 | $332.35 | $13.6M | -2.9% | -9.8% | +12.2% |
| BGNE | SELL | 2021-06-28 | 2021-06-30 | $354.97 | $683K | -3.7% | -7.8% | +6.0% |
| BGNE | SELL | 2021-06-18 | 2021-06-21 | $325.66 | $305K | +8.9% | -4.5% | +24.1% |
| BGNE | SELL | 2021-06-07 | 2021-06-09 | $351.55 | $424K | -6.2% | -5.1% | -0.1% |
| BGNE | SELL | 2021-05-28 | 2021-06-02 | $358.76 | $1.1M | -2.3% | -3.8% | -12.6% |
| BGNE | SELL | 2021-04-29 | 2021-05-03 | $354.93 | $532K | -7.2% | +7.2% | -1.6% |
| BGNE | SELL | 2021-03-29 | 2021-03-31 | $324.12 | $810K | -14.1% | -1.8% | +2.1% |
| BGNE | SELL | 2021-02-26 | 2021-03-02 | $320.83 | $610K | +4.1% | +10.7% | +18.7% |
| BGNE | SELL | 2021-01-29 | 2021-02-02 | $322.29 | $610K | +8.2% | -17.8% | -4.1% |
| BGNE | SELL | 2020-12-29 | 2020-12-30 | $249.13 | $374K | +12.0% | +24.0% | +29.1% |
| BGNE | SELL | 2020-11-30 | 2020-12-02 | $267.82 | $402K | -0.1% | +14.4% | +34.3% |
| BGNE | SELL | 2020-10-29 | 2020-11-02 | $299.98 | $828K | -5.6% | -24.4% | +15.5% |
| BGNE | SELL | 2020-09-29 | 2020-10-01 | $280.47 | $625K | +7.3% | +5.8% | -9.8% |
| BGNE | SELL | 2020-09-03 | 2020-09-08 | $233.13 | $1.1M | +16.8% | +28.5% | -4.7% |
| BGNE | SELL | 2020-08-28 | 2020-09-01 | $242.21 | $727K | +7.9% | +23.0% | +10.2% |
| BGNE | SELL | 2020-07-29 | 2020-07-31 | $209.80 | $986K | +0.3% | +13.7% | +40.9% |
| BGNE | SELL | 2020-07-07 | 2020-07-09 | $200.00 | $784K | +24.2% | +4.7% | +48.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.